Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial

被引：0
|
作者：
B Eliasson
S Gudbjörnsdottir
J Cederholm
Y Liang
F Vercruysse
U Smith
机构：
[1] Lundberg Laboratory for Diabetes Research,Department of Public Health and Caring Sciences
[2] Sahlgrenska University Hospital,undefined
[3] Göteborg University,undefined
[4] Family Medicine and Epidemiology Section,undefined
[5] University Hospital,undefined
[6] Johnson and Johnson Pharmaceutical Research and Development,undefined
[7] Johnson & Johnson Pharmaceutical Research and Development,undefined
来源：
International Journal of Obesity | 2007年 / 31卷
关键词：
human; diabetes; insulin sensitivity; HbA1c; body composition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1140 / 1147
页数：7
相关论文
共 50 条
  • [1] Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients:: randomized double-blind placebo-controlled trial
    Eliasson, B.
    Gudbjornsdottir, S.
    Liang, Y.
    Vercruysse, F.
    Smith, U.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (07) : 1140 - 1147
  • [2] The Effects of Topiramate on Weight Gain in Patients with Schizophrenia: A Double-Blind Randomized Placebo-Controlled Clinical Trial
    Jamilian, Hamidreza
    Shayganfard, Mehran
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2018, 8 (02): : 55 - 59
  • [3] Effects Of Saffron Supplementation On Inflammation And Metabolic Responses In Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
    Ebrahimi, Fatemeh
    Sahebkar, Amirhossein
    Aryaeian, Naheed
    Pahlavani, Naseh
    Fallah, Soudabeh
    Moradi, Nariman
    Abbasi, Davoud
    Hosseini, Agha Fatemeh
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2107 - 2115
  • [4] A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients
    Rosenstock, Julio
    Hollander, Priscilla
    Gadde, Kishore M.
    Sun, Xiang
    Strauss, Richard
    Leung, Albert
    DIABETES CARE, 2007, 30 (06) : 1480 - 1486
  • [5] Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial
    Nickel, C
    Tritt, K
    Muehlbacher, M
    Gil, FP
    Mitterlehner, FO
    Kaplan, P
    Lahmann, C
    Leiberich, PK
    Krawczyk, J
    Kettler, C
    Rother, WK
    Loew, TH
    Nickel, MK
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2005, 38 (04) : 295 - 300
  • [6] Effects of sibutramine in overweight poorly controlled Chinese female type 2 diabetic patients: a randomized, double-blind, placebo-controlled study
    Wang, TF
    Pei, D
    Li, JC
    Kuo, SW
    DIABETOLOGIA, 2005, 48 : A291 - A292
  • [7] Double-blind placebo-controlled trial of topiramate in SUNCT
    Cohen, Anna
    Goadsby, P.
    Matharu, M.
    CEPHALALGIA, 2007, 27 (06) : 758 - 758
  • [8] Evaluating probiotic efficacy on weight loss in adults with overweight through a double-blind, placebo-controlled randomized trial
    Danielsson, Pernilla
    Putri, Resthie R.
    Marcus, Claude
    Hagman, Emilia
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] Evaluating probiotic efficacy on weight loss in adults with overweight through a double-blind, placebo-controlled randomized trial
    Pernilla Danielsson
    Resthie R. Putri
    Claude Marcus
    Emilia Hagman
    Scientific Reports, 13
  • [10] Topiramate for migraine prevention in children: A randomized, double-blind, placebo-controlled trial
    Winner, P
    Pearlman, EM
    Linder, SL
    Jordan, DM
    Fisher, AC
    Hulihan, J
    HEADACHE, 2005, 45 (10): : 1304 - 1312
12345